Science & Technology
Mon, July 28, 2025
[ Mon, Jul 28th ]: CBS News
[ Mon, Jul 28th ]: The Weather Channel
[ Mon, Jul 28th ]: The New York Times
[ Mon, Jul 28th ]: The Jerusalem Post Blogs
[ Mon, Jul 28th ]: Phys.org
[ Mon, Jul 28th ]: yahoo.com
[ Mon, Jul 28th ]: The Cool Down
[ Mon, Jul 28th ]: Forbes
[ Mon, Jul 28th ]: The Motley Fool
[ Mon, Jul 28th ]: Chicago Tribune
[ Mon, Jul 28th ]: KCBD
[ Mon, Jul 28th ]: Impacts
[ Mon, Jul 28th ]: Seeking Alpha
[ Mon, Jul 28th ]: Organic Authority
[ Mon, Jul 28th ]: World Socialist Web Site
[ Mon, Jul 28th ]: IBTimes UK
Sun, July 27, 2025
[ Sun, Jul 27th ]: The New Indian Express
[ Sun, Jul 27th ]: Local 12 WKRC Cincinnati
[ Sun, Jul 27th ]: The Telegraph
[ Sun, Jul 27th ]: Good Housekeeping
[ Sun, Jul 27th ]: GovCon Wire
[ Sun, Jul 27th ]: The Jerusalem Post Blogs
[ Sun, Jul 27th ]: Forbes
[ Sun, Jul 27th ]: The Financial Express
Sat, July 26, 2025
[ Sat, Jul 26th ]: Reuters
[ Sat, Jul 26th ]: The News International
[ Sat, Jul 26th ]: KTVU
[ Sat, Jul 26th ]: Forbes
[ Sat, Jul 26th ]: Futurism
[ Sat, Jul 26th ]: lbbonline
[ Sat, Jul 26th ]: Phys.org
[ Sat, Jul 26th ]: NJ.com
[ Sat, Jul 26th ]: The Cool Down
[ Sat, Jul 26th ]: HuffPost Life
[ Sat, Jul 26th ]: The Jerusalem Post Blogs
[ Sat, Jul 26th ]: Live Science
[ Sat, Jul 26th ]: The Motley Fool
[ Sat, Jul 26th ]: thedispatch.com
[ Sat, Jul 26th ]: Salon
[ Sat, Jul 26th ]: WTVO Rockford
[ Sat, Jul 26th ]: yahoo.com
[ Sat, Jul 26th ]: ZDNet
[ Sat, Jul 26th ]: Impacts
[ Sat, Jul 26th ]: BBC
[ Sat, Jul 26th ]: Seeking Alpha
[ Sat, Jul 26th ]: The Globe and Mail
[ Sat, Jul 26th ]: London Evening Standard
[ Sat, Jul 26th ]: The New Indian Express
Fri, July 25, 2025
[ Fri, Jul 25th ]: NBC Washington
[ Fri, Jul 25th ]: 13abc
[ Fri, Jul 25th ]: CBS News
[ Fri, Jul 25th ]: The Observer, La Grande, Ore.
[ Fri, Jul 25th ]: reuters.com
[ Fri, Jul 25th ]: Upper
[ Fri, Jul 25th ]: Investopedia
[ Fri, Jul 25th ]: Associated Press
[ Fri, Jul 25th ]: The Motley Fool
[ Fri, Jul 25th ]: Cleveland.com
[ Fri, Jul 25th ]: Newsweek
[ Fri, Jul 25th ]: KOAT Albuquerque
[ Fri, Jul 25th ]: The Cool Down
[ Fri, Jul 25th ]: Fox News
[ Fri, Jul 25th ]: Space.com
[ Fri, Jul 25th ]: Forbes
[ Fri, Jul 25th ]: Fortune
[ Fri, Jul 25th ]: The Boston Globe
[ Fri, Jul 25th ]: Leader-Telegram, Eau Claire, Wis.
[ Fri, Jul 25th ]: Madrid Universal
[ Fri, Jul 25th ]: moneycontrol.com
[ Fri, Jul 25th ]: Ghanaweb.com
[ Fri, Jul 25th ]: Impacts
[ Fri, Jul 25th ]: Daily Record
[ Fri, Jul 25th ]: newsbytesapp.com
Thu, July 24, 2025
[ Thu, Jul 24th ]: WABI-TV
[ Thu, Jul 24th ]: WAFF
[ Thu, Jul 24th ]: HELLO! Magazine
[ Thu, Jul 24th ]: St. Louis Post-Dispatch
[ Thu, Jul 24th ]: thetimes.com
[ Thu, Jul 24th ]: Impacts
[ Thu, Jul 24th ]: The Hill
[ Thu, Jul 24th ]: Action News Jax
[ Thu, Jul 24th ]: Fox News
[ Thu, Jul 24th ]: NBC 6 South Florida
[ Thu, Jul 24th ]: Live Science
[ Thu, Jul 24th ]: sportskeeda.com
[ Thu, Jul 24th ]: Defense News
[ Thu, Jul 24th ]: Seeking Alpha
[ Thu, Jul 24th ]: CNET
[ Thu, Jul 24th ]: yahoo.com
[ Thu, Jul 24th ]: London Evening Standard
[ Thu, Jul 24th ]: The 74
[ Thu, Jul 24th ]: Ukrayinska Pravda
[ Thu, Jul 24th ]: Rhode Island Current
[ Thu, Jul 24th ]: The Decatur Daily, Ala.
[ Thu, Jul 24th ]: Foreign Policy
[ Thu, Jul 24th ]: Florida Today
[ Thu, Jul 24th ]: MassLive
[ Thu, Jul 24th ]: Business Today
[ Thu, Jul 24th ]: The Cool Down
[ Thu, Jul 24th ]: WFXT
[ Thu, Jul 24th ]: Newsweek
[ Thu, Jul 24th ]: Associated Press Finance
[ Thu, Jul 24th ]: Milwaukee Journal Sentinel
[ Thu, Jul 24th ]: The Straits Times
[ Thu, Jul 24th ]: The Sun
[ Thu, Jul 24th ]: newsbytesapp.com
[ Thu, Jul 24th ]: Forbes
[ Thu, Jul 24th ]: BBC
[ Thu, Jul 24th ]: WFTV
[ Thu, Jul 24th ]: TechCrunch
[ Thu, Jul 24th ]: The Michigan Daily
[ Thu, Jul 24th ]: moneycontrol.com
Wed, July 23, 2025
[ Wed, Jul 23rd ]: People
[ Wed, Jul 23rd ]: Today
[ Wed, Jul 23rd ]: ABC News
[ Wed, Jul 23rd ]: WESH
[ Wed, Jul 23rd ]: ABC
[ Wed, Jul 23rd ]: Seeking Alpha
[ Wed, Jul 23rd ]: Politico
[ Wed, Jul 23rd ]: yahoo.com
[ Wed, Jul 23rd ]: Atlanta Journal-Constitution
[ Wed, Jul 23rd ]: The Motley Fool
[ Wed, Jul 23rd ]: reuters.com
[ Wed, Jul 23rd ]: Telangana Today
[ Wed, Jul 23rd ]: Fox News
[ Wed, Jul 23rd ]: Newsweek
[ Wed, Jul 23rd ]: Medscape
[ Wed, Jul 23rd ]: The Scotsman
[ Wed, Jul 23rd ]: Deseret News
[ Wed, Jul 23rd ]: Forbes
[ Wed, Jul 23rd ]: KWCH
[ Wed, Jul 23rd ]: ThePrint
[ Wed, Jul 23rd ]: New Jersey Monitor
[ Wed, Jul 23rd ]: moneycontrol.com
[ Wed, Jul 23rd ]: Milwaukee Journal Sentinel
[ Wed, Jul 23rd ]: Daily Express
Tue, July 22, 2025
[ Tue, Jul 22nd ]: Fox 13
[ Tue, Jul 22nd ]: newsbytesapp.com
[ Tue, Jul 22nd ]: CNBC
[ Tue, Jul 22nd ]: Forbes
[ Tue, Jul 22nd ]: The Hill
[ Tue, Jul 22nd ]: KBTX
[ Tue, Jul 22nd ]: Detroit News
[ Tue, Jul 22nd ]: Fox News
[ Tue, Jul 22nd ]: The Independent
[ Tue, Jul 22nd ]: NBC DFW
[ Tue, Jul 22nd ]: Phys.org
[ Tue, Jul 22nd ]: Post-Bulletin, Rochester, Minn.
[ Tue, Jul 22nd ]: STAT
[ Tue, Jul 22nd ]: Associated Press
[ Tue, Jul 22nd ]: Newsweek
[ Tue, Jul 22nd ]: Space.com
[ Tue, Jul 22nd ]: Channel 3000
[ Tue, Jul 22nd ]: Tacoma News Tribune
[ Tue, Jul 22nd ]: The 74
[ Tue, Jul 22nd ]: Orlando Sentinel
[ Tue, Jul 22nd ]: Auburn Citizen
[ Tue, Jul 22nd ]: Impacts
[ Tue, Jul 22nd ]: BBC
Mon, July 21, 2025
[ Mon, Jul 21st ]: AFP
[ Mon, Jul 21st ]: ESPN
[ Mon, Jul 21st ]: al.com
[ Mon, Jul 21st ]: Forbes
[ Mon, Jul 21st ]: WFRV Green Bay
[ Mon, Jul 21st ]: Organic Authority
[ Mon, Jul 21st ]: Fox News
[ Mon, Jul 21st ]: gadgets360
[ Mon, Jul 21st ]: CNN
[ Mon, Jul 21st ]: USA TODAY
[ Mon, Jul 21st ]: NBC New York
[ Mon, Jul 21st ]: CBS News
[ Mon, Jul 21st ]: Seeking Alpha
[ Mon, Jul 21st ]: NJ.com
[ Mon, Jul 21st ]: Reuters
[ Mon, Jul 21st ]: Stateline
[ Mon, Jul 21st ]: Philadelphia Inquirer
Sun, July 20, 2025
[ Sun, Jul 20th ]: ABC
[ Sun, Jul 20th ]: Pacific Daily News
[ Sun, Jul 20th ]: The Cool Down
[ Sun, Jul 20th ]: New Hampshire Union Leader
[ Sun, Jul 20th ]: The New Indian Express
[ Sun, Jul 20th ]: reuters.com
[ Sun, Jul 20th ]: Chowhound
[ Sun, Jul 20th ]: KSNF Joplin
[ Sun, Jul 20th ]: The Atlantic
[ Sun, Jul 20th ]: WFTV
[ Sun, Jul 20th ]: CBS News
[ Sun, Jul 20th ]: The Daily Dot
[ Sun, Jul 20th ]: Backyard Garden Lover
[ Sun, Jul 20th ]: Forbes
[ Sun, Jul 20th ]: The Jerusalem Post Blogs
[ Sun, Jul 20th ]: Impacts
[ Sun, Jul 20th ]: The Citizen
[ Sun, Jul 20th ]: Business Today
Sat, July 19, 2025
[ Sat, Jul 19th ]: Sports Illustrated
[ Sat, Jul 19th ]: gizmodo.com
[ Sat, Jul 19th ]: CBS News
[ Sat, Jul 19th ]: Daily Record
[ Sat, Jul 19th ]: moneycontrol.com
[ Sat, Jul 19th ]: The Hans India
Using Technology in Service of Compassion: How Seva Foundation Merges Science and Humanity to Transform Global Eye Care
//science-technology.news-articles.net/content/2 .. e-and-humanity-to-transform-global-eye-care.html
Published in Science and Technology on Monday, July 21st 2025 at 14:23 GMT by USA TODAY🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
The organization, which has spent more than four decades combating preventable blindness around the world, is equally rooted in rigorous research, cutting-edge technology, and a culture of deep compassion.
Using Technology in Service of Compassion: How Seva Foundation Merges Science and Humanity to Transform Lives
In an era where technological advancements often seem to outpace our capacity for empathy, one organization stands as a beacon of hope, proving that innovation can be harnessed not just for progress, but for profound human connection. The Seva Foundation, a global nonprofit dedicated to eliminating preventable blindness and restoring sight, exemplifies this harmonious blend of cutting-edge science and deep-seated compassion. Founded in 1978 by a group of visionary activists, including public health pioneers and spiritual leaders like Dr. Larry Brilliant and Ram Dass, Seva has grown into a powerhouse that has restored vision to over 50 million people worldwide. But beyond the numbers lies a story of how technology, when infused with humanity, can truly transform lives—particularly in underserved communities where access to basic healthcare remains a distant dream.
At its core, Seva's mission is rooted in the Sanskrit word "seva," meaning selfless service. This philosophy drives every initiative, ensuring that technological tools are not ends in themselves but means to alleviate suffering. One of the foundation's flagship programs involves deploying advanced diagnostic technologies in remote eye care camps across Asia, Africa, and Latin America. Imagine a mobile clinic in rural India, where a simple smartphone app equipped with artificial intelligence (AI) scans a patient's retina in minutes, detecting conditions like diabetic retinopathy or glaucoma that might otherwise go unnoticed until it's too late. This isn't science fiction; it's the reality Seva has created through partnerships with tech giants and innovative startups.
Take, for instance, Seva's collaboration with companies like Google and Microsoft to develop AI-driven screening tools. These technologies use machine learning algorithms trained on vast datasets of eye images to identify abnormalities with remarkable accuracy—often surpassing human experts in speed and consistency. In regions where ophthalmologists are scarce, with ratios as dire as one doctor per million people in some African nations, these tools act as force multipliers. A community health worker, armed with a portable fundus camera and a tablet, can screen hundreds of patients in a single day, flagging cases for immediate intervention. This democratizes eye care, bridging the gap between high-tech labs in Silicon Valley and dusty villages in Nepal.
But Seva's approach goes far beyond gadgets. It's the human element that elevates their work from mere efficiency to genuine transformation. Training local healthcare providers is a cornerstone of their model, ensuring sustainability long after international teams depart. In Bangladesh, for example, Seva has empowered thousands of women as vision technicians, not only providing them with livelihoods but also challenging gender norms in conservative societies. These women, often from marginalized backgrounds, become the frontline warriors against blindness, using telemedicine platforms to consult with specialists thousands of miles away. A patient in a remote clinic might have their eye scan uploaded to the cloud, where an expert in the U.S. or India reviews it in real-time, offering diagnoses and treatment plans via video call. This fusion of technology and training has led to a ripple effect: restored sight means regained independence, allowing individuals to return to work, support their families, and contribute to their communities.
The impact is perhaps most vividly illustrated through personal stories. Consider the case of Raju, a farmer in rural Gujarat, India, who lost his vision to cataracts at age 45. Unable to work his fields, he fell into poverty, his family struggling to make ends meet. Through a Seva-organized eye camp, Raju underwent a quick, affordable cataract surgery—facilitated by portable surgical equipment and subsidized by the foundation's donors. Post-surgery, with his sight restored, Raju not only resumed farming but also became an advocate, encouraging others in his village to seek screenings. Such narratives are common in Seva's annals, where technology serves as the scalpel, but compassion is the guiding hand.
Seva's innovative use of data analytics further amplifies their reach. By aggregating anonymized patient data from across their programs, they create predictive models to anticipate outbreaks of eye diseases in vulnerable populations. For instance, in areas prone to vitamin A deficiency—a leading cause of childhood blindness—Seva deploys targeted interventions, combining nutritional supplements with community education campaigns. This data-driven strategy, powered by cloud computing and big data tools, allows for proactive rather than reactive care, preventing blindness before it takes hold.
Moreover, Seva has pioneered the integration of virtual reality (VR) in surgical training. Young ophthalmologists in training programs across Asia use VR simulations to practice complex procedures, honing their skills without risking patient safety. This not only accelerates the learning curve but also makes high-quality training accessible in resource-limited settings. In partnership with universities and tech firms, Seva has developed these modules to mimic real-world scenarios, complete with haptic feedback that simulates the feel of surgical instruments. The result? A new generation of eye care professionals equipped to handle the growing global burden of vision impairment, which the World Health Organization estimates affects 2.2 billion people, with nearly half of cases preventable.
Yet, challenges persist. Funding remains a perpetual hurdle, as Seva relies on a mix of individual donations, corporate sponsorships, and grants to sustain its operations. The foundation also navigates complex geopolitical landscapes, from conflict zones in the Middle East to climate-vulnerable islands in the Pacific, where rising sea levels exacerbate health disparities. Despite these obstacles, Seva's commitment to equity ensures that technology benefits the most marginalized. Their "Sight for All" initiative, for example, focuses on indigenous communities, adapting tools to cultural contexts—such as translating apps into local languages and incorporating traditional healing practices alongside modern medicine.
Looking ahead, Seva is poised to expand its technological arsenal. Emerging fields like gene therapy and nanotechnology hold promise for treating previously incurable conditions, and the foundation is already exploring pilot projects in these areas. Imagine nanoscale robots delivering targeted treatments to the eye, or CRISPR-based edits correcting genetic defects causing inherited blindness. While these innovations are still in nascent stages, Seva's track record suggests they will be deployed with the same compassionate ethos that has defined the organization for nearly five decades.
What sets Seva apart is its holistic view: technology is not a panacea but a tool in service of humanity. As Dr. Suzanne Gilbert, Seva's Senior Director, often emphasizes, "Our work is about seeing—not just with the eyes, but with the heart." This sentiment resonates in every program, from mass screenings in Tibetan refugee camps to partnerships with Native American tribes in the U.S., where Seva addresses diabetes-related vision loss through culturally sensitive tech interventions.
In a world grappling with inequality, Seva Foundation offers a compelling model: one where silicon chips and human kindness converge to illuminate lives. By merging the precision of science with the warmth of compassion, they remind us that true progress is measured not in gigabytes or algorithms, but in the smiles of those who can see the world anew. As global challenges like aging populations and climate change intensify the need for accessible eye care, Seva's work serves as an inspiration, proving that technology, when wielded with empathy, can indeed heal the world—one pair of eyes at a time.
(Word count: 1,048)
Read the Full USA Today Article at:
[ https://www.usatoday.com/story/special/contributor-content/2025/07/21/using-technology-in-service-of-compassion-how-seva-foundation-merges-science-and-humanity-to-transfo/85311669007/ ]